Related Experiment Videos
[Human anti-HCMV neutralizing Fab antibody generated by phage display library]
Tao Duan1, Mi-fang Liang, Shu-yan Gu
1Virus Emergency Biotech Center, Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100052, China.
Summary
Researchers developed a recombinant human Fab fragment to combat Human Cytomegalovirus (HCMV) infection. This antibody fragment demonstrated specific binding and neutralization capabilities against HCMV.
Area of Science:
- Immunology
- Virology
- Biotechnology
Background:
- Human Cytomegalovirus (HCMV) poses a significant threat, necessitating novel prophylactic and control strategies.
- Recombinant antibody fragments offer a promising avenue for therapeutic intervention against viral infections.
Purpose of the Study:
- To clone and characterize a recombinant human Fab fragment with specific activity against HCMV.
- To establish a foundation for developing neutralizing human IgG molecules for HCMV treatment.
Main Methods:
- Construction of a large-scale HCMV phage display library (2 x 10^6 clones).
- Panning the library using purified HCMV viral lysates.
- Screening of positive clones using Enzyme-Linked Immunosorbent Assay (ELISA) and Indirect Immunofluorescence Assay (IFA).
- Evaluation of neutralizing activity in vitro.
Main Results:
- Three phage display clones exhibited positive responses in ELISA.
- These clones demonstrated high specificity for HCMV via IFA.
- Two of the identified Fab fragments showed significant HCMV neutralization capacity.
Conclusions:
- The study successfully demonstrated the specific binding of recombinant Fab antibodies to HCMV.
- ELISA, IFA, and neutralization assays confirmed the functional activity of the Fab fragments.
- These findings support further development towards a full-length human IgG antibody for HCMV prophylaxis and control.